Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$60.67 - $89.12 $204,093 - $299,799
3,364 New
3,364 $229,000
Q2 2022

Aug 09, 2022

BUY
$43.23 - $73.83 $52,913 - $90,367
1,224 New
1,224 $74,000
Q4 2021

Feb 11, 2022

SELL
$70.09 - $111.29 $646,089 - $1.03 Million
-9,218 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$110.2 - $156.64 $855,592 - $1.22 Million
7,764 Added 533.98%
9,218 $1.03 Million
Q2 2021

Aug 12, 2021

SELL
$100.84 - $161.89 $25,714 - $41,281
-255 Reduced 14.92%
1,454 $235,000
Q1 2021

May 17, 2021

SELL
$110.72 - $210.04 $222,879 - $422,810
-2,013 Reduced 54.08%
1,709 $208,000
Q4 2020

Feb 09, 2021

BUY
$79.67 - $173.23 $28,123 - $61,150
353 Added 10.48%
3,722 $570,000
Q3 2020

Nov 12, 2020

SELL
$78.5 - $100.64 $435,204 - $557,948
-5,544 Reduced 62.2%
3,369 $282,000
Q2 2020

Jul 27, 2020

BUY
$38.5 - $76.05 $343,150 - $677,833
8,913 New
8,913 $655,000
Q2 2019

Jul 19, 2019

SELL
$35.45 - $48.2 $26,835 - $36,487
-757 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$28.02 - $40.87 $1,933 - $2,820
69 Added 10.03%
757 $27,000
Q4 2018

Feb 13, 2019

SELL
$22.73 - $42.34 $5,455 - $10,161
-240 Reduced 25.86%
688 $20,000
Q3 2018

Nov 14, 2018

SELL
$44.35 - $65.71 $79,741 - $118,146
-1,798 Reduced 65.96%
928 $41,000
Q2 2018

Aug 03, 2018

BUY
$42.62 - $73.59 $77,824 - $134,375
1,826 Added 202.89%
2,726 $160,000
Q1 2018

Apr 20, 2018

BUY
$23.52 - $58.17 $21,168 - $52,353
900 New
900 $41,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $2.95B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Sea Crest Wealth Management, LLC Portfolio

Follow Sea Crest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.